In this vein, RET+ NSCLC data are consistent with those coming from other oncogene-addicted NSCLCs, such as ALK+, EGFR+, and ROS1+ [38,39,40,41,42]. The gene discussed is RET; the disease is non-small cell lung carcinoma.